Inlyta 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FA3WV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,791
Award facts
- Contract value 100% obligated
- $23,791.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,791.44 delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. INLYTA (axitinib) is a tyrosine kinase inhibitor used in cancer treatment, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a global pharmaceutical support mechanism enabling the company to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The contract structure demonstrates the Defense Logistics Agency's reliance on qualified prime vendors to efficiently deliver critical pharmaceutical products to the Defense Health Agency and other federal healthcare systems on an as-needed basis through individual delivery orders.
Quick answers
Who was awarded contract SPE2DB25FA3WV?
SPE2DB25FA3WV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FA3WV worth?
The government has obligated $23,791 on SPE2DB25FA3WV.
Is contract SPE2DB25FA3WV an order under another contract?
Yes. SPE2DB25FA3WV is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA3WV competed?
The extent of competition for SPE2DB25FA3WV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award